Expert Opinion on Drug Safety, 1474-0338
Journal
Related Publications
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases
Kosse, L. J., Jessurun, N. T., Vonkeman, H. E., Tas, S. W., Nurmohamed, M. T., Hoentjen, F., van Doorn, M. B. A., van Puijenbroek, E. P., van den Bemt, B. J. F. & de Vries, M., 30-Jul-2020, In : Expert Opinion on Drug Safety. 11, p. 1521-1528 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
Kosse, L. J., Weits, G., Vonkeman, H. E., Spuls, P. I., Van Den Bemt, B. J. F., Tas, S. W., Hoentjen, F., Nurmohamed, M. T., Van Doorn, M. B. A., Van Puijenbroek, E. P. & Jessurun, N. T., 2020, In : Expert Opinion on Drug Safety. 19, 8, p. 1049-1054 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Safety profile of non-vitamin K oral anticoagulants (NOACs) from a patient perspective: A web-based cohort event monitoring study
Rolfes, L., Ekhart, C., Hendriks, J., van der Horst, P. & van Puijenbroek, E., 2019, In : Expert Opinion on Drug Safety. 18, 9, p. 869-874 6 p.Research output: Contribution to journal › Article › Academic › peer-review
First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports
Oosterhuis, I., Rolfes, L., Ekhart, C., Muller-Hansma, A. & Harmark, L., 2018, In : Expert Opinion on Drug Safety. 17, 2, p. 111-115 5 p.Research output: Contribution to journal › Article › Academic › peer-review
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
Groenman, A. P., Schweren, L. J. S., Dietrich, A. & Hoekstra, P. J., Apr-2017, In : Expert Opinion on Drug Safety. 16, 4, p. 455-464 10 p.Research output: Contribution to journal › Review article › Academic › peer-review
ID: 2387572